SARC016 Phase II study of the mTOR inhibitor RAD 001 (everolimus) with and without bevacizumab in patients with sporadic and neurofibromatosis type 1 (NF1) related refractory malignant peripheral nerve sheath tumors

Project: Research project

Project Details

StatusFinished
Effective start/end date12/1/1211/30/15

Funding

  • Sarcoma Alliance for Research Through Collaboration